Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
WHO grants Sinopharm’s COVID-19 vaccine emergency approval
The World Health Organization (WHO) has approved Sinopharm’s COVID-19 vaccine for emergency use, making it the first jab developed by a non-Western company to gain this recommendation.
Orphazyme announces topline data from pivotal trial of arimoclomol in Amyotrophic Lateral Sclerosis (ALS)
COPENHAGEN, Denmark I May 8, 2021 I Orphazyme A/S (ORPHA.
First genetically modified mosquitoes released in US
The biotech firm Oxitec has released its genetically modified mosquitoes in the Florida Keys, with the goal of suppressing wild, disease-carrying mosquito populations in the region.
Pfizer/BioNTech seek full FDA approval for their Covid-19 vaccine
(CNN)Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday.
FDA grants accelerated approval to pembrolizumab for HER2-positive gastric cancer
On May 5, 2021, the Food and Drug Administration granted accelerated approval to pembrolizumab (Keytruda, Merck & Co.
FDA extends tie-up with CN Bio to test ‘lung-on-a-chip’ tech
The FDA has extended a collaboration with the UK firm CN Bio to investigate a “lung-on-a-chip” model to investigate inhaled drugs.
US supports waiving IP for COVID vaccines
The Biden-Harris Administration has voiced support for waiving intellectual property protections for COVID vaccines, in the hope of ramping up access in low-income countries hit by the virus, marking ...
Tecentriq approved for first-line metastatic NSCLC
Roche’s checkpoint inhibitor Tecentriq has gained a new approval from the European Commission, for the first-line treatment of certain patients with metastatic non-small cell lung cancer (NSCLC&...
Moderna lifts COVID-19 vaccine sales forecast to $19.2 billion
(Reuters) -Moderna Inc raised its 2021 sales forecast for its COVID-19 shot by 4.
Lilly hit by staff accusations, FDA scrutiny at COVID drug factories
Сотрудники Eli Lilly & Co (LLY.
AZ’s Farxiga scores US approval in chronic kidney disease
The US Food and Drug Administration (FDA) has approved AstraZeneca’s (AZ) oral SGLT2 inhibitor Farxiga for the treatment of chronic kidney disease (CKD) in adults at risk of ...
Janssen seeks EU approval for first CAR-T therapy cilta-cel
Johnson & Johnson’s (J&J) pharma division Janssen has filed its first CAR-T cell therapy ciltacabtagene autoleucel (cilta-cel) with the European Medicines Agency (EMA)...
252
253
254
255
256
257
258
259
260
